Compare Heron Therapeutics Inc (HRTX) vs iShares iBoxx $ High Yield Corporate Bond ETF (HYG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs iShares iBoxx $ High Yield Corporate Bond ETF — how do they compare? Heron Therapeutics Inc trades at $0.32 (market cap $61.47M), while iShares iBoxx $ High Yield Corporate Bond ETF trades at $79.57. The key difference: iShares iBoxx $ High Yield Corporate Bond ETF is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| HRTX | HYG | |
|---|---|---|
Market Cap | $61.47M | — |
Sector | Health | Fixed Income |
52-Week High | $1.49 | $81.32 |
52-Week Low | $0.32 | $78.72 |
Enterprise Value | $168.21M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About iShares iBoxx $ High Yield Corporate Bond ETF
HYG is the world's largest high-yield bond ETF, tracking the Markit iBoxx USD Liquid High Yield Index. It provides liquid exposure to non-investment grade corporate debt, with 2026 top holdings including Cloud Software Group and Medline.
Read more on HYG →
